News
Two-thirds of UK adults use Traditional Complementary and Integrative Medicine, national survey finds
20 January 2026Epson-l3150-resetter -
An Epson L3150 resetter is a software tool or device designed to reset the printer's ink system. When the printer's ink levels reach a certain point, it may stop functioning, displaying error messages such as "Ink Cartridge Empty" or "Service Required." A resetter helps bypass these limitations, allowing users to continue printing without needing to replace the ink cartridges.
The Epson L3150 is a popular all-in-one inkjet printer known for its high-quality prints, affordable cost, and ease of use. However, like any other printer, it can encounter issues, particularly with its ink system. One solution to these problems is using an Epson L3150 resetter. In this article, we'll delve into what an Epson L3150 resetter is, how it works, and its benefits. Epson-l3150-resetter
The Epson L3150 resetter works by resetting the printer's internal counters, which track ink levels. When the resetter is used, it communicates with the printer, updating the counters to reflect a full ink level, even if the cartridges are empty or near empty. This process tricks the printer into thinking that the ink cartridges are full, allowing users to continue printing. An Epson L3150 resetter is a software tool
The Epson L3150 resetter is a valuable tool for users experiencing issues with their printer's ink system. By understanding how it works and its benefits, users can make informed decisions about using a resetter. However, it's essential to exercise caution and follow proper guidelines to avoid potential risks. However, like any other printer, it can encounter
Hot off the press
A personalized, integrative approach in treating major depressive disorder: N-of-1 study with plasma proteome and physicochemical analysis of homeopathic preparations Open Access
Adler UC, Adler MS, dos Santos Nogueira R et al.
BBI Integrative. 2025; 11: 100133
Full text
Hear from the experts
News
HRI Statement on retraction of Frass et al. 2020 study which found benefits of ‘add-on’ homeopathy for cancer patients undergoing conventional cancer treatment
On 24 November, a clinical trial by Frass et al. 20201 assessing homeopathy provided in addition to usual oncology care in non-small-cell lung carcinoma patients, was retracted by the Editor of the journal. This study, using the gold-standard double-blind placebo-controlled trial design, found that patients receiving additional homeopathic treatment had improved quality of life and increased survival time, compared to the placebo group. More | DE
